Please join the VCapital team, fellow investors and special guests from the greater Chicago area entrepreneurial and deal-making community for an end-of-the-work-day social get-together on Wednesday, July 17th, from 4:30 to 6:30pm, at the JW Marriott at 151 West Adams, Chicago, IL 60603.
The event highlight will be two keynote speakers, Harvard Medical School’s world-renowned geneticist Professor George Church and molecular biologist Professor Ting Wu (bios below). They will speak on a wide variety of subjects including the human genome (which many consider the most important key to the future of medicine), anti-aging, bringing back woolly mammoths, the use of DNA for massive data storage and a number of startups that have emerged from their labs. With healthcare accounting for a 17% and still growing share of the US economy, their presentation will not only stimulate but also offer highly relevant investment intelligence.
Supplementing this investment-relevant intellectual, there will be cocktails and hors d’oeuvres in a comfortable venue perfect for networking and relaxing after the workday.
This event is an opportunity to get together with other BVC/VCapital investors and friends of the firm and learn about interesting and relevant topics from two experts. While there will be no specific investment presentation this evening, we are always looking to expand our investor base. A larger pool of potential investors benefits all of us by increasing diversification and expanding our ability to offer more and higher quality deals. In that light, we ask that you consider inviting like-minded guests to join in the fun. We welcome anyone you feel would like to learn more about the firm and meet other VCapital members.
George Church is a Professor of Genetics at Harvard Medical School and Director of PersonalGenomes.org, which provides the world’s only open-access information on human Genomic, Environmental & Trait data (GET). His 1984 Harvard PhD dissertation included the first methods for direct genome sequencing, molecular multiplexing and barcoding. These led to the first genome sequence in 1994. His lab’s innovations have contributed to nearly all “next generation” DNA sequencing methods and companies. His work on chip-DNA-synthesis, gene editing and stem cell engineering have resulted as well in additional application-based companies spanning fields of medical diagnostics and synthetic biology / therapeutics. He has co-authored 514 papers and 143 patent publications.
Ting Wu is a Professor of Genetics at Harvard Medical School, as well as Director of the Consortium for Space Genetics and Director of the Personal Genetics Education Project. She is the recipient of an NIH Director’s 2012 Pioneer Award for her laboratory’s work on genome organization, homolog pairing, and inheritance and an NIH Director’s 2016 Transformative Research Award for work on sequence ultra-conservation as a strategy for maintaining genome integrity. Her team has developed a variety of technologies, ranging from strategies that facilitate genome engineering to those that enable high-throughput screening of entire genomes using fluorescent in situ hybridization (Hi-FISH). She and her co-workers also invented the Oligopaints method for in situ visualization of DNA and RNA.